NCT00743431
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Ovarian Diseases
Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.
3,399 public trials
657 recruiting studies
Ovarian Diseases trial results
NCT00451568
- Conditions
- Adnexal Diseases, Cysts, Endocrine System Diseases, +10 more
- Locations
-
- Odense University Hospital Odense, Denmark
NCT01242436
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- University Hospital Gasthuisberg Leuven, Belgium
NCT00346385
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +38 more
- Locations
-
- University of California San Francisco San Francisco, California, United States
- Nevada Cancer Institute Las Vegas, Nevada, United States
- The Ohio State University Cancer Center and Research Institute Columbus, Ohio, United States
- Oklahoma University Oklahoma City, Oklahoma, United States
NCT01675310
- Conditions
- Adnexal Diseases, Body Weight, Cysts, +25 more
- Locations
-
- National Institute of Perinatology México, State of Mexico, Mexico
NCT02385396
- Conditions
- Adnexal Diseases, Cysts, Endocrine System Diseases, +11 more
- Locations
-
- Medical University of Lublin Lublin, Lublin Voivodeship, Poland
NCT01234012
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +41 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- New York University (NYU) Cancer Center New York, United States
Completed
Pilot Study of Taxol, Carboplatin, and Bevacizumab in Advanced Stage Ovarian Carcinoma Patients
NCT00127920
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- Gynecologic Oncology Associates Newport Beach, California, United States
- Florida Hospital College of Health Sciences Orlando, Florida, United States
Completed
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
NCT00345540
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Dana Farber Cancer/Partners Cancer Care Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT01227928
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- GSK Investigational Site Guangzhou, Guangdong, China
- GSK Investigational Site Nanjing, Jiangsu, China
- GSK Investigational Site Shenyang, Liaoning, China
- GSK Investigational Site Jinan, Shandong, China